Declined acceptance rates of medicine taken into the Dutch reimbursement system after the introduction of the new Zorginstituut Nederland guideline on the 26th of June 2015.

Bandraz, Reza (2020) Declined acceptance rates of medicine taken into the Dutch reimbursement system after the introduction of the new Zorginstituut Nederland guideline on the 26th of June 2015. Research Project, Pharmacy.

Preview	Text Declined acceptance rates of medicine taken into the Dutch reimbursement system after the introduction of the new ZIN guideline on the 26th of June 2015. Postma database research by Reza Bandraz (1) (1).pdf Download (1MB) | Preview
	Text toestemming.pdf Restricted to Registered users only Download (98kB)

Abstract

Background: The ZIN introduced a new guideline on the 26th of June 2015 for the reimbursement of medicine into the Dutch healthcare system. This guideline was introduced to provide more clearance on the reimbursement criteria and to emphasize the importance of costs-effectiveness as a criterion. After the introduction of this guideline no known data has been published on its effects on the reimbursement of medicine. This study therefore outlined the trends on cost-effectiveness decisions made by the ZIN from March 2006 until April 2017 and searched for trends around the introduction of the new guideline. Methods: A database research on medicine with a cost-effectiveness analysis was performed. The data was extracted from the ZIN website and included medicine offered for reimbursement between March 2006 and April 2017. Descriptive statistics were performed to search for overall trends. The Pearson Chi-square Test and the Fisher’s Exact Test were used to assess the difference in acceptance rates of medicine offered for reimbursement before and after the introduction of the new ZIN guidelines. Results: The median acceptance rate of all medicine offered for reimbursement declined significantly with 53% after the introduction of the new ZIN guideline (p=0.009 and power=0.92). For cancer medicine specifically, the acceptance rates declined with 61% (p=0.015). Discussion/Conclusion: The new ZIN guideline emphasizes cost-effectiveness and contains additional criterion on cost

Item Type:	Thesis (Research Project)
Supervisor name:	Postma, M.J.
Degree programme:	Pharmacy
Thesis type:	Research Project
Language:	English
Date Deposited:	28 Apr 2020 09:05
Last Modified:	28 Apr 2020 09:05
URI:	https://fse.studenttheses.ub.rug.nl/id/eprint/21807

Actions (login required)

View Item